TALLARIG - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Image for trademark with serial number 86885795
Serial Number
86885795
Word Mark
TALLARIG
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2019-08-26
Filing Date
2016-01-25
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2016-05-31
Law Office Assigned Location Code
M20
Employee Name
MCCRAY, RENEE D
Statements
Goods and Services
Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
Translation of Words in Mark
The wording "TALLARIG" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2016-01-29
Primary Code
005
Correspondences
Name
SUSAN J. HINCHEY
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2016-01-28NEW APPLICATION ENTERED IN TRAM
2016-01-29NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2016-03-29ASSIGNED TO EXAMINER
2016-04-01EXAMINERS AMENDMENT -WRITTEN
2016-04-01EXAMINERS AMENDMENT E-MAILED
2016-04-01NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2016-04-01EXAMINER'S AMENDMENT ENTERED
2016-04-02APPROVED FOR PUB - PRINCIPAL REGISTER
2016-04-19ASSIGNED TO LIE
2016-04-26LAW OFFICE PUBLICATION REVIEW COMPLETED
2016-05-11NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2016-05-31PUBLISHED FOR OPPOSITION
2016-05-31OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2016-07-26NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2017-01-05TEAS EXTENSION RECEIVED
2017-01-05EXTENSION 1 FILED
2017-01-05EXTENSION 1 GRANTED
2017-01-07NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2017-06-13TEAS EXTENSION RECEIVED
2017-06-13EXTENSION 2 FILED
2017-06-13EXTENSION 2 GRANTED
2017-06-15NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-01-12TEAS EXTENSION RECEIVED
2018-01-12EXTENSION 3 FILED
2018-01-12EXTENSION 3 GRANTED
2018-01-16NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-07-17TEAS EXTENSION RECEIVED
2018-07-17EXTENSION 4 FILED
2018-07-17EXTENSION 4 GRANTED
2018-07-19NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-08-15AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2019-01-22TEAS EXTENSION RECEIVED
2019-01-31CASE ASSIGNED TO INTENT TO USE PARALEGAL
2019-01-22EXTENSION 5 FILED
2019-02-01EXTENSION 5 GRANTED
2019-02-02NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-08-26ABANDONMENT - NO USE STATEMENT FILED
2019-08-26ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED